Pseudotumor cerebri in patient on leuprolide acetate for central precocious puberty

BACKGROUND: Gonadotropin releasing hormone agonists (GnRHa) are well established as a standard of care for the treatment of central precocious puberty (CPP) worldwide. While numerous delivery systems and routes of administration exist, depot intramuscular injections or sustained-release preparations...

Descripción completa

Detalles Bibliográficos
Autores principales: Omar, Anjumanara Anver, Nyaga, Godfrey, Mungai, Lucy N Wainaina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712604/
https://www.ncbi.nlm.nih.gov/pubmed/33292495
http://dx.doi.org/10.1186/s13633-020-00092-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7712604/
https://www.ncbi.nlm.nih.gov/pubmed/33292495
http://dx.doi.org/10.1186/s13633-020-00092-4

Ejemplares similares